Satellos Bioscicence Inc.

Symbol: TSXV: MSCL OTCPK: MSCLF
Market Cap: 10M
Purpose Raise Awareness, Open Market Buying

Sector: Biotech
Summary:
  • Satellos Bioscience Inc. is a biotechnology company developing small molecule drugs to restore the regenerative capacity of muscle as a disease modifying therapeutic approach to devastating muscle conditions
  • The Company’s lead program is focused on correcting a regeneration deficit it discovered to be a root cause of the progressive muscle loss in Duchenne muscular dystrophy, a lethal genetic disease with no cure
  • Satellos believes its technology is game changing and can be applied to a range of dystrophies, atrophies and fraility/aging.